HKU ICB

Dr. Yin is the Founder and Managing Partner of San Yi Innovation Investment Management Company.  San Yi Innovation Investment Management Company is an investment institution focusing on the field of biomedical innovation. Before founding San Yi Innovation Investment Management Co., Ltd., Dr. Yin  served as the managing director of SDIC Innovation Investment Management Co., Ltd., focusing on equity investment in the biomedical industry. The main investment projects include Dizhe, Ascent, CanSino, Ribo, Cinda, Borui et al.

Dr. Yin Zheng has accumulated multi-level and rich industry experience in the field of biomedicine. While working abroad, he served in biotechnology companies and Novartis, a large multinational pharmaceutical company, and was responsible for new drug creation and project management. After returning to China, he worked in famous universities for teaching, scientific research, management, and consulting work related to biomedicine. He has served as dean of the School of Pharmacy at Nankai University, deputy director of the State Key Laboratory of Medicinal Chemical Biology, and executive director of the Center for Basic Molecular Science at Tsinghua University; and served in many state level industry and technology professional committees. 
 
Dr. Yin Zheng holds a bachelor's degree and a master's degree from Nankai University, and a doctoral degree in science from the National University of Singapore.